Dipeptidyl-peptidase-IV inhibition augments postprandial lipid mobilization and oxidation in type 2 diabetic patients.

Boschmann, Michael

Dipeptidyl-peptidase-IV inhibition augments postprandial lipid mobilization and oxidation in type 2 diabetic patients. [electronic resource] - The Journal of clinical endocrinology and metabolism Mar 2009 - 846-52 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1945-7197

10.1210/jc.2008-1400 doi


Adamantane--analogs & derivatives
Adipose Tissue--metabolism
Adult
Aged
Cross-Over Studies
Diabetes Mellitus, Type 2--drug therapy
Dipeptidyl-Peptidase IV Inhibitors--pharmacology
Double-Blind Method
Female
Glucagon-Like Peptide 1--physiology
Humans
Hypoglycemic Agents--pharmacology
Lipid Mobilization--drug effects
Male
Middle Aged
Muscle, Skeletal--metabolism
Nitriles--pharmacology
Norepinephrine--blood
Oxidation-Reduction
Postprandial Period--physiology
Pyrrolidines--pharmacology
Vildagliptin